Alethia Young
CIK 1918147 · View on SEC EDGAR ↗
First SEC filing: June 12, 2026 · Latest: June 12, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 10, 2026 | PCRX | A | 10,891 | — | — | 10,891 Direct | — | Acquired | (price as of 2026-08-20) |
| June 10, 2026 | PCRX | A | 6,405 | — | — | 17,798 Direct | +56.22% | Acquired | (price as of 2026-08-20) |
| June 11, 2025 | PCRX | A | 6,163 | — | — | 11,393 Direct | +117.84% | Acquired | (price as of 2026-08-20) |
| June 11, 2025 | PCRX | A | 11,279 | — | — | 11,279 Direct | — | Acquired | (price as of 2026-08-20) |
| June 12, 2024 | PCRX | A | 5,230 | — | — | 5,230 Direct | — | Acquired | (price as of 2026-08-20) |
| June 12, 2024 | PCRX | A | 12,179 | — | — | 12,179 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 2, 2024 | BCYC | A | 24,000 | — | — | 24,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 2, 2024 | BCYC | A | 12,000 | — | — | 12,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 6, 2023 | PCRX | A | 30,967 | — | — | 30,967 Direct | — | Acquired | (price as of 2026-08-20) |
| July 17, 2023 | BCYC | A | 120,000 | — | — | 120,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 21, 2023 | LENZ | A | 220,000 | — | — | 220,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2022 | PTCT | A | 3,200 | — | — | 3,200 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2022 | PTCT | A | 1,867 | — | — | 5,067 Direct | +58.34% | Acquired | (price as of 2026-08-20) |
| June 9, 2022 | PTCT | A | 12,000 | — | — | 12,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 9, 2022 | PTCT | A | 7,000 | — | — | 7,000 Direct | — | Acquired | (price as of 2026-08-20) |
| April 1, 2022 | LENZ | A | 350,000 | — | — | 350,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 10, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock (10,891) | $23.42 | June 10, 2036 | 10,891 | Acquired |
| June 11, 2025 | PCRX | Stock Option (Right to Buy) | Common Stock (11,279) | $24.34 | June 11, 2035 | 11,279 | Acquired |
| June 12, 2024 | PCRX | Stock Option (Right to Buy) | Common Stock (12,179) | $28.68 | June 12, 2034 | 12,179 | Acquired |
| Jan. 2, 2024 | BCYC | Employee Stock Option (right to buy) | Ordinary Shares (24,000) | $18.08 | Jan. 2, 2034 | 24,000 | Acquired |
| Oct. 6, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (30,967) | $29.80 | Oct. 6, 2033 | 30,967 | Acquired |
| July 17, 2023 | BCYC | Employee Share Option (Right to Buy) | Ordinary Shares (120,000) | $26.21 | July 17, 2033 | 120,000 | Acquired |
| Feb. 21, 2023 | LENZ | Stock Option (right to buy) | Common Stock (220,000) | $2.18 | Feb. 20, 2033 | 220,000 | Acquired |
| June 9, 2022 | PTCT | Stock Option (Right to Buy) | Common Stock (12,000) | $27.85 | June 8, 2032 | 12,000 | Acquired |
| June 9, 2022 | PTCT | Stock Option (Right to Buy) | Common Stock (7,000) | $27.85 | June 8, 2032 | 7,000 | Acquired |
| April 1, 2022 | LENZ | Stock Option (right to buy) | Common Stock (350,000) | $5.23 | March 31, 2032 | 350,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $337,500 | $170,000 | — | $1,212,715 | $115,274 | — | $151,350 | $1,835,489 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.